Nothing Generic about Generic Pharma Fraud

October 7, 2021

Nothing Generic about Generic Pharma Fraud October 5, 2021. Three pharmaceutical manufacturers executed both civil False Claims Act and criminal deferred prosecution agreements for a generic drug price-fixing scheme. The pharmaceutical companies paid $447.2 million to resolve alleged False Claims Act violations and $424 million for related criminal charges, for almost $900 million in damages, penalties, and fines.

Read the source article at Legal News & Business Law News
2021-10-05 20:04:52

Share This Story!